Clinical and Translational Science NRMN Furthering a Diverse Biomedical Workforce

临床和转化科学 NRMN 促进多元化的生物医学劳动力

基本信息

  • 批准号:
    8661445
  • 负责人:
  • 金额:
    $ 19.21万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-09-25 至 2014-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): An engaged diverse biomedical workforce is essential for the health of the nation. The nation faces unprecedented challenges and opportunities to develop new knowledge that can decrease healthcare disparities and improve the health of individuals. The US is not currently benefitting from the talents of all citizens. Women, under-represented minority (URM) populations, those with disabilities, those who identify as lesbian, gay, or transgender (LGBT), and those from backgrounds disadvantaged by socio-economic status, cultural or language barriers, or rural geography are all under-represented in the biomedical workforce. The talents and skills of these individuals could advance scientific disciplines allowing the nation to achieve our goals related to better health. It is in the compelling interest of the nation to nurture the talents of those currently under-represented in the biomedical workforce. Mentoring has been identified as critical in the recruitment and retention of under-represented populations in the biomedical workforce. Developing an effective national research mentoring network (NRMN) is an innovative approach to increase inclusion and diversity in biomedical research. This proposal reflects collaboration of 40 of the 60 academic health centers in the NIH Clinical and Translational Science Award (CTSA) consortium and also includes multiple partner organizations that represent constituencies often not fully included in the biomedical workforce. In order to achieve a national impact, we will leverage the CTSA consortium institutions through collaboration with national stakeholders including the CTSA Child Health Oversight Committees (CC-CHOC), the Association of Clinical and Translational Science (ACTS), the Research Partnership on Women in Science Careers (RPWSC), the Gay and Lesbian Medical Association (GLMA), and the Society of Healthcare Professionals with Disabilities (SHPD). The Specific Aims of this proposal are: 1) Develop a partnership between the CTSA institutions and other stakeholder institutions that will support the organization and governance of a NRMN; 2) Assess, categorize, and create an inventory of the existing capacity and resources at all partner institutions to recruit and mentor under-represented populations from undergraduates through junior faculty; 3) Develop strategies to adopt and disseminate existing, successful local and small-scale activities and programs for the nation; 4) Conduct a gap analysis and develop new mentorship activities, courses, infrastructure, and tools that can fill the gaps identified and support the new NRMN; and 5) Design and create the tools to evaluate and track the outcomes of the NRMN.
描述(由申请人提供):参与的生物医学劳动力对国家的健康至关重要。该国面临着前所未有的挑战和机会,以发展可以减少医疗保健差异并改善个人健康的新知识。美国目前并未从所有公民的才华中受益。妇女,代表性不足的少数群体(URM)人口,残疾人,认同为女同性恋,同性恋或变性者(LGBT)的妇女,以及因社会经济地位,文化或语言障碍或农村地理位置而遭受的背景的妇女,在生物范围内均未得到社会经济地位,文化或农村地理位置的影响。这些人的才能和技能可以提高科学学科,使国家实现与改善健康有关的目标。培育生物医学劳动力中目前代表性不足的人的才能是备受强大的兴趣。在生物医学劳动力中,指导在招募和保留不足的人群中至关重要。开发有效的国家研究指导网络(NRMN)是一种创新的方法,可以增加生物医学研究中的包容性和多样性。该提案反映了NIH临床和转化科学奖(CTSA)联盟中60个学术保健中心中有40个合作,还包括多个代表组成部分的合作伙伴组织,这些组织通常不完全包含在生物医学员工中。为了实现全国影响,我们将通过与包括CTSA儿童健康监督委员会(CC-CHOC)(CC-CHOC),临床和转化科学协会(ACTS)(ACTS)的国家利益相关者合作来利用CTSA联盟机构,研究妇女职业妇女(RPWSC)(RPWSC)的研究合作伙伴关系(RPWSC),与lesbian医疗协会(GLMA)(SCRICEABS)和SHAR CASS(SHAR)(SHAR)(SHARC)(SHAR)(SHAR)(SHARC)。该提案的具体目的是:1)在CTSA机构与其他利益相关者机构之间建立合作伙伴关系,这些机构将支持NRMN的组织和治理; 2)评估,分类并创建所有合作伙伴机构的现有能力和资源的清单,以从本科生到初级教师从本科生招募和指导不足的人口; 3)制定采用和传播现有的,成功的本地和小规模活动和计划的策略; 4)进行差距分析并开发新的指导活动,课程,基础设施和工具,以填补差距并支持新的NRMN; 5)设计和创建评估和跟踪NRMN结果的工具。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Carrie L. Byington其他文献

Carrie L. Byington的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Carrie L. Byington', 18)}}的其他基金

Novel Testing to Elucidate Reproductive Outcomes of ZIKV Infection - Olympics 2016
阐明 ZIKV 感染生殖后果的新测试 - 2016 年奥运会
  • 批准号:
    9265224
  • 财政年份:
    2016
  • 资助金额:
    $ 19.21万
  • 项目类别:
University of Utah Center for clinical and Translational Science
犹他大学临床和转化科学中心
  • 批准号:
    8720945
  • 财政年份:
    2013
  • 资助金额:
    $ 19.21万
  • 项目类别:
University of Utah Center for clinical and Translational Science
犹他大学临床和转化科学中心
  • 批准号:
    8743323
  • 财政年份:
    2013
  • 资助金额:
    $ 19.21万
  • 项目类别:
University of Utah Center for Clinical and Translational Science
犹他大学临床和转化科学中心
  • 批准号:
    8899720
  • 财政年份:
    2013
  • 资助金额:
    $ 19.21万
  • 项目类别:
University of Utah Center for Clinical and Translational Science
犹他大学临床和转化科学中心
  • 批准号:
    8743325
  • 财政年份:
    2013
  • 资助金额:
    $ 19.21万
  • 项目类别:
University of Utah Center for clinical and Translational Science
犹他大学临床和转化科学中心
  • 批准号:
    8720938
  • 财政年份:
    2013
  • 资助金额:
    $ 19.21万
  • 项目类别:
University of Utah Center for clinical and Translational Science
犹他大学临床和转化科学中心
  • 批准号:
    8899719
  • 财政年份:
    2013
  • 资助金额:
    $ 19.21万
  • 项目类别:
University of Utah Center for Clinical and Translational Science
犹他大学临床和转化科学中心
  • 批准号:
    8720951
  • 财政年份:
    2013
  • 资助金额:
    $ 19.21万
  • 项目类别:
University of Utah Center for clinical and Translational Science
犹他大学临床和转化科学中心
  • 批准号:
    8899718
  • 财政年份:
    2013
  • 资助金额:
    $ 19.21万
  • 项目类别:
University of Utah Center for clinical and Translational Science
犹他大学临床和转化科学中心
  • 批准号:
    8743324
  • 财政年份:
    2013
  • 资助金额:
    $ 19.21万
  • 项目类别:

相似海外基金

Clinical Feasibility of Wireless Catheter-Free Urodynamics for Extended, Comprehensive Urological Evaluation in the Home Setting
无线无导管尿动力学在家庭环境中进行扩展、综合泌尿外科评估的临床可行性
  • 批准号:
    10762486
  • 财政年份:
    2023
  • 资助金额:
    $ 19.21万
  • 项目类别:
The Neuronal Effect of CHI3L1 in Neuroinflammation & Alzheimer's Disease
CHI3L1 在神经炎症中的神经元作用
  • 批准号:
    10679915
  • 财政年份:
    2023
  • 资助金额:
    $ 19.21万
  • 项目类别:
Novel Mechanisms in the Resolution of Post-Surgical Lymphedema
解决术后淋巴水肿的新机制
  • 批准号:
    10580412
  • 财政年份:
    2023
  • 资助金额:
    $ 19.21万
  • 项目类别:
Defining The Role of Failed-Repair Proximal Tubule Cells in AdvancedRenal Disease in African Americans
确定修复失败的近端小管细胞在非裔美国人晚期肾病中的作用
  • 批准号:
    10740665
  • 财政年份:
    2023
  • 资助金额:
    $ 19.21万
  • 项目类别:
Implementation Science and Equity
实施科学与公平
  • 批准号:
    10557509
  • 财政年份:
    2023
  • 资助金额:
    $ 19.21万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了